Rejuvenation therapies.jpg

Tuesday 28 April

5pm EU: 4pm UK: 11am EDT: 8am PDT

Rejuvenation therapies

2.5 hours split over 3 sessions … Followed by ‘Ask me anything’ session for VIP ticket holders

Session 1

Phil Newman

Editor-In-Chief, Longevity.Technology

Review of Day 1 in the context of rejuvenation therapies and introductions.

Jamie Metzl

Author, Technology Futurist

Scene-setter and session introduction

Aubrey de Grey

Founder and CEO, SENS Foundation

The divide-and-conquer nature of rejuvenation can be an asset, not a challenge

Nir Barzilai

Director, Institute for Aging Research

How do we show in humans that a drug targets aging?

Ilaria Bellantuono

Professor in Musculoskeletal Ageing, Co-Director, The Healthy Lifespan Institute, Department of Oncology and Metabolism

Geroprotectors: time to change the way we treat older people?

Gary Hudson

Executive Chairman, Oisín Biotechnologies

Removal of senescent cells to extend healthspan & lifespan

5 minute coffee/bio break 🙂

Session 2


Co-founder and CEO Repair Biotechnologies & Fight Aging!

The undeveloped hinterland of rejuvenation

Nina Khera

Co-Founder, Biotein

Group discussion with various Day 2 speakers

Nina Khera

Co-Founder, Biotein

Finding novel therapies for zombie cells using Artificial Intelligence

Michael D West

Chief Executive Officer, AgeX Therapeutics

Supercentenarians – reprogramming cells (TBC)

Joan Mannick

Chief Medical Officer, resTORbio

The use of TORC1 inhibitors to improve immune function in the elderly

5 minute coffee/bio break 🙂

Session 3

Vadim Gladyshev

Professor of Medicine and Director, Center for Redox Medicine, Brigham and Women’s Hospital, Harvard Medical School, USA

From Longevity signatures to Longevity interventions

João Pedro de Magalhães

Senior Lecturer, University of Liverpool

Anti-aging biotech: past, present and future

Bryant Villeponteau

Chairman and Chief Scientific Officer, Centagen, Inc.

Rejuvenated stem cells to reverse aging

Jamie Metzl

Author, Technology Futurist

Review of content and group discussion

Phil Newman

Editor-In-Chief, Longevity.Technology

Close and introduction to ‘Ask Me Anything’ session for VIP ticket holders

Please note: speakers, presentation titles and running order may change. This page is updated daily. Thanks.

Ask Me Anything

For VIP ticket holders only

A closed session with delegates and a selection of key speakers to address questions from the day and other key questions.